Decision: Favourable
Study Title:
A phase III, randomized, double-masked, placebo controlled, parallel-group, multicenter study of the safety and efficacy of OT-101 (Atropine 0.01%) in treating the progression of myopia in pediatric subjects
NREC Code:
21-NREC-CT-007
Decision:
Favourable
Meeting Date:
16/06/2021
Study Type:
CT application
Principal Investigator:
Prof Daniel Ian Flitcroft
PI Institution:
TU Dublin and Mater University Hospital
Sponsor:
Ocumension (Hong Kong) Limited